Search Results

Your search matched 30 results

#1

Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives

Virtual delivery requires you to rethink your content and approaches.

#2

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#3

Best Practices: Social Media Content and Activity During COVID-19 | Perspectives

In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."

#4

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#5

Here are a Few Changes We Can Expect to See in Our World After COVID | Blog

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#6

Is Your Mask Up to the Task? | Blog

Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”

#7

The Syneos Health Podcast, Coronavirus Special Edition: Payers and COVID-19 | Perspectives

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#8

How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#9

PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog

How COVID-19 and 3 other barriers will transform healthcare over the next few years.

#10

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#11

Demonstrating Value in the Real World | Perspectives

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#12

It's Time for a Digital Reset | Perspectives

What should the evolution of your digital strategy look like through COVID-19 and beyond?

#13

Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives

To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.

#14

Meet Think Bank | Perspectives

Think Bank is an agile way to answer complex questions.

#15

Our Virtual Reality | Perspectives

Virtual collaboration isn’t the future of work – it's the wave of the present

#16

Payer Priorities in a Pandemic | In The Media

What are payers focused on during the COVID-19 pandemic?

#17

2020 Employee Communications and Behavioral Science Contingency | Perspectives

Recommendations for activities to inform and engage

#18

Life Sciences Commercialization in the COVID-19 Era: Critical Pivot Points to Mitigate Risk | Perspectives

Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.

#19

Microsoft and GE Healthcare Team Up to Create New Virtual-Care Technology | Blog

At a time when most clinicians are overwhelmed and overworked, Microsoft and GE Healthcare are partnering together to help ease the burden of patient monitoring with a new cloud-based tool.

#20

Pivot Past the Pandemic | Perspectives

Life sciences commercialization in the COVID-19 era and beyond

#21

MM&M eBook: Marketing in a Crisis | In The Media

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#22

There’s a Looming Mental Health Crisis but Tech is Here to Help | Blog

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#23

COVID-19: How are Payers Managing These Days? | Perspectives

How are payers responding to COVID-19?

#24

Contingency 2020: Four Strategic Ways to Maintain Momentum Through Disruption | Perspectives

Four Rapid Response Approaches To Maintain Business Momentum

#25

The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives

In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.

#26

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#27

Four Critical Dynamics for Virtual Collaboration | Blog

Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.

#28

Clearing a Commercial Path for Novel Cancer Therapeutics in a Post-Pandemic World | Perspectives

Part I of a Syneos Health Series on New Oncology Commercialization Strategies

#29

It’s Time to Rethink How Pharma Can Unleash the Potential of AI | Perspectives

The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development.

#30

The Syneos Health Podcast, Coronavirus Special Edition: The Leader's Experience | Perspectives

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.